Filing Details
- Accession Number:
- 0001209191-19-039557
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-28 19:59:24
- Reporting Period:
- 2019-06-26
- Accepted Time:
- 2019-06-28 19:59:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1406652 | C Douglas Bryant | 12544 High Bluff Drive, Suite 200 San Diego CA 92130 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-06-26 | 5,838 | $12.63 | 307,280 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-06-26 | 19,412 | $15.19 | 326,692 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-06-26 | 25,250 | $57.25 | 301,442 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-06-28 | 3,461 | $15.19 | 304,903 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-06-28 | 3,461 | $60.06 | 301,442 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Options | Disposition | 2019-06-26 | 5,838 | $0.00 | 5,838 | $12.63 |
| Common Stock | Non-Qualified Stock Options | Disposition | 2019-06-26 | 19,412 | $0.00 | 19,412 | $15.19 |
| Common Stock | Non-Qualified Stock Option | Disposition | 2019-06-28 | 3,461 | $0.00 | 3,461 | $15.19 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-03-02 | No | 4 | M | Direct | |
| 100,981 | 2022-03-02 | No | 4 | M | Direct | |
| 97,520 | 2022-03-02 | No | 4 | M | Direct |
Footnotes
- The weighted average sale price for these transactions was $57.252 per share, with a range of $56.80 to $57.62. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- The weighted average sale price for these transactions was $60.06 per share, with a range of $60.00 to $60.17. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- 42,959 shares vested on 03/02/2013; 21,479 shares vested on 03/02/2014; 21,480 shares vested on 03/02/2015.
- 60,196 shares vested on 03/02/2014; 30,098 shares vested on 03/02/2015; and 30,099 shares vested on 03/02/2016.
Billionaire Hedge Funds
